Shu Shen

机构：Sichuan University, West China Hospital of Sichuan University · ORCID：0000-0002-4737-171X

发表论文 61 篇 · 总被引 857 次 · h-index 16

代表论文

• Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm (2022 · Frontiers in Immunology · 被引 80)
• Evaluating the Benefits and Risks of Ex Vivo Liver Resection and Autotransplantation in Treating Hepatic End-stage Alveolar Echinococcosis (2022 · Clinical Infectious Diseases · 被引 16)
• Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion (2022 · Frontiers in Oncology · 被引 13)
• High PD-1 and CTLA-4 expression correlates with host immune suppression in patients and a mouse model infected with Echinococcus multilocularis (2024 · Parasites & Vectors · 被引 8)
• Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study (2021 · Japanese Journal of Clinical Oncology · 被引 8)
• Responsive biomaterials for therapeutic strategies of hepatocellular carcinoma (2025 · Frontiers in Bioengineering and Biotechnology · 被引 7)